An instrument for estimating the 6-month survival probability after whole-brain irradiation alone for cerebral metastases from gynecological cancer

Stefan Janssen, Heinke C. Hansen, Steven E. Schild, Dirk Rades

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background/Aim: Patients with cerebral metastases from gynecological cancer who receive whole-brain irradiation (WBI) alone require personalized therapy. This study contributes to personalized care by creating an instrument to predict 6-month survival probability. Patients and Methods: In 49 patients, six pre-treatment variables, namely age, Eastern Cooperative Oncology Group performance score (ECOG-PS), primary tumor type, number of cerebral metastases, metastasis outside the brain, and interval between diagnosis of gynecological cancer and WBI, were analyzed for survival. Results: Of the six pre-treatment variables, ECOG-PS was significantly associated with survival (p=0.014) and metastasis outside the brain showed a trend for association (p=0.096). Six-month survival rates divided by 10 resulted in scores of 0, 2 or 7 points for ECOG-PS and of 2 or 7 points for metastasis outside the brain. Scores for individual patients were 2, 4, 7, 9 or 14 points. Three groups were created, those with 2-7, 9 and 14 points, with 6-month survival rates of 10%, 53% and 100%, respectively (p=0.004). Conclusion: An instrument was designed to predict the 6-month survival of patients receiving WBI for cerebral metastases from gynecological cancer and facilitate personalized care.

Original languageEnglish (US)
Pages (from-to)3753-3756
Number of pages4
JournalAnticancer Research
Volume38
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Neoplasm Metastasis
Survival
Brain
Neoplasms
Survival Rate
Brain Neoplasms
Therapeutics

Keywords

  • 6-month survival probability
  • Brain metastases
  • Gynecological cancer
  • Prognostic instrument
  • Whole-brain irradiation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

An instrument for estimating the 6-month survival probability after whole-brain irradiation alone for cerebral metastases from gynecological cancer. / Janssen, Stefan; Hansen, Heinke C.; Schild, Steven E.; Rades, Dirk.

In: Anticancer Research, Vol. 38, No. 6, 01.06.2018, p. 3753-3756.

Research output: Contribution to journalArticle

Janssen, Stefan ; Hansen, Heinke C. ; Schild, Steven E. ; Rades, Dirk. / An instrument for estimating the 6-month survival probability after whole-brain irradiation alone for cerebral metastases from gynecological cancer. In: Anticancer Research. 2018 ; Vol. 38, No. 6. pp. 3753-3756.
@article{2b916382bf414d069d38a681497bf40a,
title = "An instrument for estimating the 6-month survival probability after whole-brain irradiation alone for cerebral metastases from gynecological cancer",
abstract = "Background/Aim: Patients with cerebral metastases from gynecological cancer who receive whole-brain irradiation (WBI) alone require personalized therapy. This study contributes to personalized care by creating an instrument to predict 6-month survival probability. Patients and Methods: In 49 patients, six pre-treatment variables, namely age, Eastern Cooperative Oncology Group performance score (ECOG-PS), primary tumor type, number of cerebral metastases, metastasis outside the brain, and interval between diagnosis of gynecological cancer and WBI, were analyzed for survival. Results: Of the six pre-treatment variables, ECOG-PS was significantly associated with survival (p=0.014) and metastasis outside the brain showed a trend for association (p=0.096). Six-month survival rates divided by 10 resulted in scores of 0, 2 or 7 points for ECOG-PS and of 2 or 7 points for metastasis outside the brain. Scores for individual patients were 2, 4, 7, 9 or 14 points. Three groups were created, those with 2-7, 9 and 14 points, with 6-month survival rates of 10{\%}, 53{\%} and 100{\%}, respectively (p=0.004). Conclusion: An instrument was designed to predict the 6-month survival of patients receiving WBI for cerebral metastases from gynecological cancer and facilitate personalized care.",
keywords = "6-month survival probability, Brain metastases, Gynecological cancer, Prognostic instrument, Whole-brain irradiation",
author = "Stefan Janssen and Hansen, {Heinke C.} and Schild, {Steven E.} and Dirk Rades",
year = "2018",
month = "6",
day = "1",
doi = "10.21873/anticanres.12656",
language = "English (US)",
volume = "38",
pages = "3753--3756",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - An instrument for estimating the 6-month survival probability after whole-brain irradiation alone for cerebral metastases from gynecological cancer

AU - Janssen, Stefan

AU - Hansen, Heinke C.

AU - Schild, Steven E.

AU - Rades, Dirk

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background/Aim: Patients with cerebral metastases from gynecological cancer who receive whole-brain irradiation (WBI) alone require personalized therapy. This study contributes to personalized care by creating an instrument to predict 6-month survival probability. Patients and Methods: In 49 patients, six pre-treatment variables, namely age, Eastern Cooperative Oncology Group performance score (ECOG-PS), primary tumor type, number of cerebral metastases, metastasis outside the brain, and interval between diagnosis of gynecological cancer and WBI, were analyzed for survival. Results: Of the six pre-treatment variables, ECOG-PS was significantly associated with survival (p=0.014) and metastasis outside the brain showed a trend for association (p=0.096). Six-month survival rates divided by 10 resulted in scores of 0, 2 or 7 points for ECOG-PS and of 2 or 7 points for metastasis outside the brain. Scores for individual patients were 2, 4, 7, 9 or 14 points. Three groups were created, those with 2-7, 9 and 14 points, with 6-month survival rates of 10%, 53% and 100%, respectively (p=0.004). Conclusion: An instrument was designed to predict the 6-month survival of patients receiving WBI for cerebral metastases from gynecological cancer and facilitate personalized care.

AB - Background/Aim: Patients with cerebral metastases from gynecological cancer who receive whole-brain irradiation (WBI) alone require personalized therapy. This study contributes to personalized care by creating an instrument to predict 6-month survival probability. Patients and Methods: In 49 patients, six pre-treatment variables, namely age, Eastern Cooperative Oncology Group performance score (ECOG-PS), primary tumor type, number of cerebral metastases, metastasis outside the brain, and interval between diagnosis of gynecological cancer and WBI, were analyzed for survival. Results: Of the six pre-treatment variables, ECOG-PS was significantly associated with survival (p=0.014) and metastasis outside the brain showed a trend for association (p=0.096). Six-month survival rates divided by 10 resulted in scores of 0, 2 or 7 points for ECOG-PS and of 2 or 7 points for metastasis outside the brain. Scores for individual patients were 2, 4, 7, 9 or 14 points. Three groups were created, those with 2-7, 9 and 14 points, with 6-month survival rates of 10%, 53% and 100%, respectively (p=0.004). Conclusion: An instrument was designed to predict the 6-month survival of patients receiving WBI for cerebral metastases from gynecological cancer and facilitate personalized care.

KW - 6-month survival probability

KW - Brain metastases

KW - Gynecological cancer

KW - Prognostic instrument

KW - Whole-brain irradiation

UR - http://www.scopus.com/inward/record.url?scp=85048221232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048221232&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12656

DO - 10.21873/anticanres.12656

M3 - Article

C2 - 29848738

AN - SCOPUS:85048221232

VL - 38

SP - 3753

EP - 3756

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -